A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis

A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis

Abstract Worldwide, stroke is a leading cause of long-term disability in adults. Alteplase is the only approved treatment for acute ischemic stroke (AIS) and results in an improvement in a third of treated patients. Most studies evaluated the post-alteplase haemorrhagic transformation of brain infar...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed G. Zeinhom, Sherihan Rezk Ahmed, Ahmed Mohamed Kohail, Islam Fathallah Mohamed Kamel, ALshimaa Mahfouz Abdelrahman, Omar M. AL-Nozha, Mohamed Almoataz, Tarek Youssif Omar Youssif, Ahmed Mohamed Ali Daabis, Hossam Mohamed Refat, Ahmed Ahmed Mohamed Kamal Ebied, Ahmed Elbassiouny, Ahmed Zaki Omar Akl, Ashfaq Shuaib, Mohamed Ismaiel, Asmaa Ibrahem Desouky Mostafa Ibrahem, Mohamed Fouad Elsayed Khalil
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Alteplase
Hemorrhagic infarction
Egypt
Saudi Arabia
Middle east
Online Access:https://doi.org/10.1038/s41598-024-76189-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-024-76189-0

Similar Items